Megan Boxall

You won’t get the vaccine by the Spring, but that might not matter

When it comes to Blue Prism's robotics processing, short seller Shadowfall has raised the same concerns as the Investors Chronicle

Testing and vaccine progress is encouraging, but the care sector has many hurdles to overcome

ITV’s financial results suggest a downward spiral of demand which might pave the way to the end of British television

Is Pfizer’s announcement a shot in the arm for markets or a stab in the dark?

Daily updates as the results roll in

Four scenarios to consider in the wake of the closest election in a generation

With less than a week to go until polling day, US media outlets are braced for a challenge

Megan Boxall and John Hughman explain how private companies are key to the survival of the NHS

Third quarter fail to reflect the confidence of the famed fund manager